Northern Trust’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Northern Trust’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,091	Closed	-$73.5K	–	4548
2023 Q2	$73.5K	Hold	19,091	–	–	﹤0.01%	4119
2023 Q1	$57.7K	Buy	19,091 +2,048	+12%	+$7.08K	﹤0.01%	4230
2022 Q4	$34.9K	Sell	17,043 -1,000	-6%	-$3.05K	﹤0.01%	4375
2022 Q3	$62K	Buy	18,043 +3,804	+27%	+$17.3K	﹤0.01%	4267
2022 Q2	$60K	Hold	14,239	–	–	﹤0.01%	4352
2022 Q1	$43K	Hold	14,239	–	–	﹤0.01%	4568
2021 Q4	$67K	Sell	14,239 -1,000	-7%	-$6.88K	﹤0.01%	4540
2021 Q3	$117K	Hold	15,239	–	–	﹤0.01%	4363
2021 Q2	$131K	Sell	15,239 -62,153	-80%	-$548K	﹤0.01%	4292
2021 Q1	$879K	Buy	+77,392	New	+$1.21M	﹤0.01%	3636

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Northern Trust's DBTX Position: Q3 2023 in Review

Northern Trust sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 19,091 shares — an estimated $73.5K sold.

Northern Trust first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $879K in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Northern Trust reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 19,091 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $73.5K.
Northern Trust first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Northern Trust's Decibel Therapeutics, Inc. Common Stock position peaked at $879K in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.